DM
TXG icon

Deerfield Management’s 10x Genomics TXG Stock Holding History

Deerfield Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-126,574
Closed -$2.06M – 151
2025
Q4 		$2.06M Sell
126,574
-134,614
-52% -$2.03M 0.03% 97
2025
Q3 		$3.05M Buy
261,188
+249,887
+2,211% +$3.26M 0.05% 87
2025
Q2 		$131K Sell
11,301
-1,492,293
-99% -$13.6M ﹤0.01% 113
2025
Q1 		$13.1M Buy
1,503,594
+6,594
+0.4% +$83.1K 0.26% 61
2024
Q4 		$21.5M Sell
1,497,000
-11,943
-0.8% -$188K 0.41% 49
2024
Q3 		$34.1M Buy
1,508,943
+911,943
+153% +$18.9M 0.51% 44
2024
Q2 		$11.6M Buy
+597,000
New +$15.6M 0.19% 65

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management's TXG Position: Q1 2026 in Review

Deerfield Management sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 126,574 shares — an estimated $2.06M sold.

Deerfield Management first reported a position in TXG in Q2 2024 and held it in 7 quarters. The position peaked at $34.1M in Q3 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Deerfield Management reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 126,574 10x Genomics shares in Q1 2026, an estimated $2.06M.
  • Deerfield Management first reported a position in 10x Genomics in Q2 2024 and held it in 7 quarters.
  • Deerfield Management's 10x Genomics position peaked at $34.1M in Q3 2024.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.